Alpine Immune Sciences Operating Income

Alpine Immune Sciences (ALPN) currently reports a operating income of $-51M as of March 2024. That compares with $-66M in the prior-year period — up 22.5% year over year. Use the charts on this page to explore Alpine Immune Sciences's operating income history and peer comparisons.

Alpine Immune Sciences's operating income increased from $-66M to $-51M — a 22.5% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alpine Immune Sciences reported $-51M in operating income as of March 2024. That compares with $-66M in the prior-year period — up 22.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alpine Immune Sciences, and consider following ALPN for alerts when major investors trade the stock.

Alpine Immune Sciences is classified in the Healthcare sector. On operating income, it currently shows $-51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALPN with unrelated industries.